Pharma, Biotech, Medtech, and Digital Health Solicitors

Pharma, Biotech, Medtech, and Digital Health
We work closely with clients in life sciences sectors – pharma, biotech, medtech, and digital health – helping them to achieve their most ambitious goals, both nationally and internationally.

The work done in the pharma, biotech, medtech, and digital healthcare sectors is not just life-enhancing but often life-saving. So their importance extends beyond their considerable economic impact.

We are active participants: over time we have developed deep knowledge of these sectors, and built strong relationships of trust with our clients. They include publicly listed companies, SMEs, start-ups and universities, among others; we advise them on a very wide range of critical matters, at every stage from concept through to production at scale. The business landscape is ever-changing, in many ways, including the regulatory regime and technological advances such as the convergence of AI and digital tech. So all businesses in these sectors need to balance risks and opportunities.

Our team includes experts in intellectual property, technology, data, corporate, commercial, employment and immigration law, all with broad experience in the sector. When international advice is required, we call on the resources available in the wider firm, and use our strong relationships in the World Services Group – a global network of 130 firms operating across 145 jurisdictions, of which we were a founder member.

Our depth of practical experience enables us to add another dimension to the advice we provide: anticipating possible future problems and ensuring that the legal arrangements we put in place minimise those risks.

Our expertise includes:

Fundraising and financing
Mergers and acquisitions
Collaborations, joint ventures and strategic partnering arrangements
Research and Development (both academic and industrial)
Clinical trial and study agreements
Protection, acquisition and licensing intellectual property
Manufacturing, supply, distribution and agency agreements
Employment, immigration and employee incentive schemes
Competition and regulation
Advertising and promotion under regulated conditions
Data protection including direct marketing, data usage and security breaches
Exports and sanctions
Inwards investment and international transactions

Meet our key contacts

Joanna Boag-Thomson

Partner

Meet our full team

Joanna Boag-Thomson

Partner

View Profile

Madeleine Gill

Solicitor

View Profile

Cameron Kane

Senior Solicitor

View Profile

Related articles and insights: Pharma, Biotech, Medtech, and Digital Health

10 February 2023

The Metaverse series – Part 5 – Employer considerations in the metaverse

Contributors:
Joanna Boag-Thomson, Gillian Moore

In the fifth and final article of our metaverse series, we will discuss the use of immersive online technology in an employment context and set out some of the considerations that employers will be grappling with if looking to harness this technology in the workplace.

9 February 2023

The Metaverse series – Part 4 – Protection of intellectual property rights

Contributors:
Joanna Boag-Thomson, Carly Duckett

Harnessing the metaverse technology provides a real opportunity for brand owners. However, it is also important for organisations to consider protecting the brand’s intellectual property (IP). This is previously unchartered territory and, as with the regulatory approach to advertising, there is a lack of clear legal guidelines or precedent. This article sets out the key points that brand owners should be considering and discusses some practical steps that can be taken at this stage to protect their IP.

8 February 2023

The Metaverse series – Part 3 – Brand considerations in the metaverse

Contributor: Joanna Boag-Thomson

The metaverse offers businesses an invaluable opportunity for advertising. However, there are still grey areas and it is not particularly clear what rules will apply to brands looking to advertise in the metaverse. This article discusses what advertising looks like in the metaverse and how brands can advertise responsibly.

7 February 2023

The Metaverse series – Part 2 – Non-fungible tokens (NFTs)

Contributor: Joanna Boag-Thomson

In the first article of this series we explored the concept of the metaverse. In this article, we will delve deeper into NFTs. Many iterations of the metaverse depend upon the use and trade of NFTs, making them a crucial component of this virtual world.

6 February 2023

The Metaverse series – Part 1 – Introduction to the metaverse

Contributor: Joanna Boag-Thomson

The growth of the metaverse presents organisations with endless opportunities to engage with their customers, grow their brand and improve communication within the workplace. Whilst these are undoubtedly exciting times, there are a number of challenges that businesses may face when utilising this technology. We have prepared a series of articles to set out the key factors that businesses should be considering.

23 September 2021

Bitter pill for the ICO to swallow as fine on pharmacy reduced

Contributor: Ruairidh Leishman

A recent appeal by a pharmacy Doorstep Dispensaree Limited was successful in reducing a Monetary Penalty Notice issued by the Information Commissioner’s Office by approximately two thirds. Ruairidh Leishman, solicitor in our commercial disptues team, explains why.

Contact us